top of page

Search

Aug 19, 20230 min read

Small exciting molecules ACS 2023 first disclosures in clinical development

Updated: Oct 9, 2023

Recent Posts

ARV-110 for the treatment of men with metastatic castration resistant prostate cancer, ARV-471 Orally Bioavailable Estrogen Receptor Degrading PROTAC®for the Treatment of Patients with Breast Cancer

An alternative to benzene rings for Medchem researchers

Comments

bottom of page